Skip to main content
Signal8

Parsons Erin

SEC insider (Form 3/4/5 filer). CIK 0001895795. Director at KIORA PHARMACEUTICALS INC (KPRX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in ENCINITAS, CA.

Companies Parsons Erin has filed insider reports for

  • KIORA PHARMACEUTICALS INC (KPRX): Director
  • ALIMERA SCIENCES INC (ALIM): Director
Parsons Erin profile photo

Parsons Erin

CIK: 0001895795

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

KIORA PHARMACEUTICALS INC logo
KPRX

KIORA PHARMACEUTICALS INC

Director
ALIMERA SCIENCES INC logo
ALIM

ALIMERA SCIENCES INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Jun 10, 2026
    Award

    Stock Option (right to buy)

    Direct
    25K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    20K shares-
  • ALIMERA SCIENCES INC logo
    ALIM

    ALIMERA SCIENCES INC

    Sep 16, 2024
    Disposition

    Stock Option (Right to Buy)

    Direct
    50K shares-
  • ALIMERA SCIENCES INC logo
    ALIM

    ALIMERA SCIENCES INC

    Sep 16, 2024
    Disposition

    Stock Option (Right to Buy)

    Direct
    6K shares-
  • ALIMERA SCIENCES INC logo
    ALIM

    ALIMERA SCIENCES INC

    Sep 16, 2024
    Disposition

    Stock Option (Right to Buy)

    Direct
    3.3K shares-

1-5 of 5